Tilray Brands (TLRY) shares are falling in pre-market trading following a fiscal third-quarter revenue miss. The cannabis-pharmaceutical stock, classified as a meme stock, has gained over 12% year-to-date. Morning Brief anchors are tracking Tilray’s performance compared to the wider cannabis industry in 2024. Watch the full episode of Morning Brief for expert insight and market updates.
Read the full story here
Written by:
Published on April 9, 2024 at 11:45PM
Source: Yahoo Finance – Business Finance, Stock Market, Quotes, News (opens in new tab)